Diabetes and the Kidney in Pregnancy

Seminars in Nephrology

Volumn 31, Issue 1, 2011, Pages 59-69

  Powe, Camille E ^a   Thadhani, Ravi ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Diabetes; Preeclampsia; Pregnancy; Renal disease

Indexed keywords

CAPTOPRIL; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; VASCULOTROPIN; VASCULOTROPIN INHIBITOR;

ARTICLE; BLOOD PRESSURE MONITORING; BLOOD PRESSURE REGULATION; CREATININE BLOOD LEVEL; DIABETIC HYPERTENSION; DIABETIC NEPHROPATHY; DISEASE COURSE; DISEASE SEVERITY; GLOMERULUS FILTRATION; GLOMERULUS FILTRATION RATE; HIGH RISK PREGNANCY; HUMAN; KIDNEY DYSFUNCTION; KIDNEY FUNCTION; KIDNEY PLASMA FLOW; KIDNEY TRANSPLANTATION; MICROALBUMINURIA; NONHUMAN; PATHOPHYSIOLOGY; PODOCYTE; PREECLAMPSIA; PREGNANCY; PREGNANCY DIABETES MELLITUS; PRIORITY JOURNAL; PROTEINURIA; RISK ASSESSMENT; RISK FACTOR;

DIABETES MELLITUS, TYPE 2; DIABETES, GESTATIONAL; DIABETIC NEPHROPATHIES; FEMALE; HUMANS; HYPERTENSION; KIDNEY; KIDNEY TRANSPLANTATION; PRE-ECLAMPSIA; PREGNANCY;

EID: 78751690569     PISSN: 02709295     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.semnephrol.2010.10.006     Document Type: Article

References (75)

1. US Renal Data System 2009 Annual Data Report. Atlas of chronic kidney disease and end-stage renal disease in the United States 2009, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD.
2. Cowie C.C., Rust K.F., Byrd-Holt D.D., et al. Prevalence of diabetes and high risk for diabetes using hemoglobin A1c criteria in the U.S. population in 1988-2006. Diabetes Care 2010, 33562-33568.
3. Albrecht S.S., Kuklina E.V., Bansil P., et al. Diabetes trends among delivery hospitalizations in the United States, 1994-2004. Diabetes Care 2010, 33:768-773.
4. Hanson U., Persson B. Epidemiology of pregnancy-induced hypertension and preeclampsia in type 1 (insulin-dependent) diabetic pregnancies in Sweden. Acta Obstet Gynecol Scand 1998, 77:620-624.
5. Khoury J.C., Miodovnik M., LeMasters G., Sibai B. Pregnancy outcome and progression of diabetic nephropathy. What's next? J Matern Fetal Neonatal Med 2002, 11:238-244.
6. Ekbom P., Damm P., Feldt-Rasmussen B., et al. Pregnancy outcome in type 1 diabetic women with microalbuminuria. Diabetes Care 2001, 24:1739-1744.
7. Haeri S., Khoury J., Kovilam O., Miodovnik M. The association of intrauterine growth abnormalities in women with type 1 diabetes mellitus complicated by vasculopathy. Am J Obstet Gynecol 2008, 199:278. e1-5.
8. Dunne F.P., Chowdhury T.A., Hartland A., et al. Pregnancy outcome in women with insulin-dependent diabetes mellitus complicated by nephropathy. QJM 1999, 92:451-454.
9. Nielsen L.R., Damm P., Mathiesen E.R. Improved pregnancy outcome in type 1 diabetic women with microalbuminuria or diabetic nephropathy: effect of intensified antihypertensive therapy? Diabetes Care 2009, 32:38-44.
10. Sibai B.M., Caritis S., Hauth J., et al. Risks of preeclampsia and adverse neonatal outcomes among women with pregestational diabetes mellitus. National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units. Am J Obstet Gynecol 2000, 182:364-369.
11. Reece E.A., Leguizamon G., Homko C. Stringent controls in diabetic nephropathy associated with optimization of pregnancy outcomes. J Matern Fetal Med 1998, 7:213-216.
12. Gordon M., Landon M.B., Samuels P., Hissrich S., Gabbe S.G. Perinatal outcome and long-term follow-up associated with modern management of diabetic nephropathy. Obstet Gynecol 1996, 87:401-409.
13. Purdy L.P., Hantsch C.E., Molitch M.E., et al. Effect of pregnancy on renal function in patients with moderate-to-severe diabetic renal insufficiency. Diabetes Care 1996, 19:1067-1074.
14. Biesenbach G., Grafinger P., Stoger H., Zazgornik J. How pregnancy influences renal function in nephropathic type 1 diabetic women depends on their pre-conceptional creatinine clearance. J Nephrol 1999, 12:41-46.
15. Biesenbach G., Stoger H., Zazgornik J. Influence of pregnancy on progression of diabetic nephropathy and subsequent requirement of renal replacement therapy in female type I diabetic patients with impaired renal function. Nephrol Dial Transplant 1992, 7:105-109.
16. Mogensen C.E., Christensen C.K., Vittinghus E. The stages in diabetic renal disease. With emphasis on the stage of incipient diabetic nephropathy. Diabetes 1983, 32. Suppl 2:64-78.
17. Keane W.F., Brenner B.M., de Zeeuw D., et al. The risk of developing end-stage renal disease in patients with type 2 diabetes and nephropathy: the RENAAL study. Kidney Int 2003, 63:1499-1507.
18. Remuzzi G., Macia M., Ruggenenti P. Prevention and treatment of diabetic renal disease in type 2 diabetes: the BENEDICT study. J Am Soc Nephrol 2006, 17. Suppl 2:S90-7.
19. Nathan D.M., Zinman B., Cleary P.A., et al. Modern-day clinical course of type 1 diabetes mellitus after 30 years' duration: the diabetes control and complications trial/epidemiology of diabetes interventions and complications and Pittsburgh epidemiology of diabetes complications experience (1983-2005). Arch Intern Med 2009, 169:1307-1316.
20. Lewis E.J., Hunsicker L.G., Bain R.P., Rohde R.D. The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The Collaborative Study Group. N Engl J Med 1993, 329:1456-1462.
21. Zoungas S., de Galan B.E., Ninomiya T., et al. Combined effects of routine blood pressure lowering and intensive glucose control on macrovascular and microvascular outcomes in patients with type 2 diabetes: new results from the ADVANCE trial. Diabetes Care 2009, 32:2068-2074.
22. Kunz R., Friedrich C., Wolbers M., Mann J.F. Meta-analysis: effect of monotherapy and combination therapy with inhibitors of the renin angiotensin system on proteinuria in renal disease. Ann Intern Med 2008, 148:30-48.
23. Ruggenenti P., Perna A., Ganeva M., Ene-Iordache B., Remuzzi G. Impact of blood pressure control and angiotensin-converting enzyme inhibitor therapy on new-onset microalbuminuria in type 2 diabetes: a post hoc analysis of the BENEDICT trial. J Am Soc Nephrol 2006, 17:3472-3481.
24. Pohl M.A., Blumenthal S., Cordonnier D.J., et al. Independent and additive impact of blood pressure control and angiotensin II receptor blockade on renal outcomes in the irbesartan diabetic nephropathy trial: clinical implications and limitations. J Am Soc Nephrol 2005, 16:3027-3037.
25. Bakris G.L., Weir M.R., Shanifar S., et al. Effects of blood pressure level on progression of diabetic nephropathy: results from the RENAAL study. Arch Intern Med 2003, 163:1555-1565.
26. Davison J.M., Dunlop W. Renal hemodynamics and tubular function normal human pregnancy. Kidney Int 1980, 18:152-161.
27. Christensen T., Klebe J.G., Bertelsen V., Hansen H.E. Changes in renal volume during normal pregnancy. Acta Obstet Gynecol Scand 1989, 68:541-543.
28. Waugh J., Bell S.C., Kilby M.D., et al. Urinary microalbumin/creatinine ratios: reference range in uncomplicated pregnancy. Clin Sci (Lond) 2003, 104:103-107.
29. Higby K., Suiter C.R., Phelps J.Y., Siler-Khodr T., Langer O. Normal values of urinary albumin and total protein excretion during pregnancy. Am J Obstet Gynecol 1994, 171:984-989.
30. Beetham R., Dawnay A., Menabawy M., Silver A. Urinary excretion of albumin and retinol-binding protein during normal pregnancy. J Clin Pathol 1988, 41:1089-1092.
31. Lindheimer M.D., Kanter D. Interpreting abnormal proteinuria in pregnancy: the need for a more pathophysiological approach. Obstet Gynecol 2010, 115:365-375.
32. Wilson M., Morganti A.A., Zervoudakis I., et al. Blood pressure, the renin-aldosterone system and sex steroids throughout normal pregnancy. Am J Med 1980, 68:97-104.
33. Biesenbach G., Zazgornik J. Incidence of transient nephrotic syndrome during pregnancy in diabetic women with and without pre-existing microalbuminuria. BMJ 1989, 299:366-367.
34. McCance D.R., Traub A.I., Harley J.M., Hadden D.R., Kennedy L. Urinary albumin excretion in diabetic pregnancy. Diabetologia 1989, 32:236-239.
35. Biesenbach G., Zazgornik J., Stoger H., et al. Abnormal increases in urinary albumin excretion during pregnancy in IDDM women with pre-existing microalbuminuria. Diabetologia 1994, 37:905-910.
36. Biesenbach G., Zazgornik J. High prevalence of hypertensive retinopathy and coronary heart disease in hypertensive patients with persistent microalbuminuria under short intensive antihypertensive therapy. Clin Nephrol 1994, 41:211-218.
37. Imbasciati E., Gregorini G., Cabiddu G., et al. Pregnancy in CKD stages 3 to 5: fetal and maternal outcomes. Am J Kidney Dis 2007, 49:753-762.
38. Sturgiss S.N., Davison J.M. Effect of pregnancy on the long-term function of renal allografts: an update. Am J Kidney Dis 1995, 26:54-56.
39. Levidiotis V., Chang S., McDonald S. Pregnancy and maternal outcomes among kidney transplant recipients. J Am Soc Nephrol 2009, 20:2433-2440.
40. Cosio F.G., Hickson L.J., Griffin M.D., Stegall M.D., Kudva Y. Patient survival and cardiovascular risk after kidney transplantation: the challenge of diabetes. Am J Transplant 2008, 8:593-599.
41. Coscia L.A., Constantinescu S., Moritz M.J., et al. Report from the National Transplantation Pregnancy Registry (NTPR): outcomes of pregnancy after transplantation. Clin Transpl 2008, 89-105.
42. Thompson B.C., Kingdon E.J., Tuck S.M., Fernando O.N., Sweny P. Pregnancy in renal transplant recipients: the Royal Free Hospital experience. QJM 2003, 96:837-844.
43. Van Winter J.T., Ogburn P.L., Ramin K.D., Evans M.P., Velosa J.A. Pregnancy after pancreatic-renal transplantation because of diabetes. Mayo Clin Proc 1997, 72:1044-1047.
44. Mastrobattista J.M., Gomez-Lobo V. Pregnancy after solid organ transplantation. Obstet Gynecol 2008, 112:919-932.
45. Barrou B.M., Gruessner A.C., Sutherland D.E., Gruessner R.W. Pregnancy after pancreas transplantation in the cyclosporine era: report from the International Pancreas Transplant Registry. Transplantation 1998, 65:524-527.
46. Joffe G.M., Esterlitz J.R., Levine R.J., et al. The relationship between abnormal glucose tolerance and hypertensive disorders of pregnancy in healthy nulliparous women. Am J Obstet Gynecol 1998, 179:1032-1037. Calcium for Preeclampsia Prevention (CPEP) Study Group.
47. Garner P.R., D'Alton M.E., Dudley D.K., Huard P., Hardie M. Preeclampsia in diabetic pregnancies. Am J Obstet Gynecol 1990, 163:505-508.
48. Goldman M., Kitzmiller J.L., Abrams B., Cowan R.M., Laros R.K. Obstetric complications with GDM. Effects of maternal weight. Diabetes 1991, 40(Suppl 2):79-82.
49. Combs C.A., Rosenn B., Kitzmiller J.L., et al. Early-pregnancy proteinuria in diabetes related to preeclampsia. Obstet Gynecol 1993, 82:802-807.
50. How H.Y., Sibai B., Lindheimer M., et al. Is early-pregnancy proteinuria associated with an increased rate of preeclampsia in women with pregestational diabetes mellitus? Am J Obstet Gynecol 2004, 190:775-778.
51. Hiilesmaa V., Suhonen L., Teramo K. Glycaemic control is associated with pre-eclampsia but not with pregnancy-induced hypertension in women with type I diabetes mellitus. Diabetologia 2000, 43:1534-1539.
52. Rowan J.A., Gao W., Hague W.M., McIntyre H.D. Glycemia and its relationship to outcomes in the metformin in gestational diabetes trial. Diabetes Care 2010, 33:9-16.
53. Landon M.B., Spong C.Y., Thom E., et al. A multicenter, randomized trial of treatment for mild gestational diabetes. N Engl J Med 2009, 361:1339-1348.
54. Crowther C.A., Hiller J.E., Moss J.R., et al. Effect of treatment of gestational diabetes mellitus on pregnancy outcomes. N Engl J Med 2005, 352:2477-2486.
55. Sunderji S., Gaziano E., Wothe D., et al. Automated assays for sVEGF R1 and PlGF as an aid in the diagnosis of preterm preeclampsia: a prospective clinical study. Am J Obstet Gynecol 2010, 202. 40e1-7.
56. Cohen A., Lim K.H., Lee Y., et al. Circulating levels of the antiangiogenic marker soluble FMS-like tyrosine kinase 1 are elevated in women with pregestational diabetes and preeclampsia: angiogenic markers in preeclampsia and preexisting diabetes. Diabetes Care 2007, 30:375-377.
57. Bakris G.L., Williams M., Dworkin L., et al. Preserving renal function in adults with hypertension and diabetes: a consensus approach. National Kidney Foundation Hypertension and Diabetes Executive Committees Working Group. Am J Kidney Dis 2000, 36:646-661.
58. de Galan B.E., Perkovic V., Ninomiya T., et al. Lowering blood pressure reduces renal events in type 2 diabetes. J Am Soc Nephrol 2009, 20:883-892.
59. Abalos E., Duley L., Steyn D.W., Henderson-Smart D.J. Antihypertensive drug therapy for mild to moderate hypertension during pregnancy. Cochrane Database Syst Rev 2007, 1:CD002252.
60. von Dadelszen P., Ornstein M.P., Bull S.B., et al. Fall in mean arterial pressure and fetal growth restriction in pregnancy hypertension: a meta-analysis. Lancet 2000, 355:87-92.
61. Carr D.B., Koontz G.L., Gardella C., et al. Diabetic nephropathy in pregnancy: suboptimal hypertensive control associated with preterm delivery. Am J Hypertens 2006, 19:513-519.
62. Shotan A., Widerhorn J., Hurst A., Elkayam U. Risks of angiotensin-converting enzyme inhibition during pregnancy: experimental and clinical evidence, potential mechanisms, and recommendations for use. Am J Med 1994, 96:451-456.
63. Cooper W.O., Hernandez-Diaz S., Arbogast P.G., et al. Major congenital malformations after first-trimester exposure to ACE inhibitors. N Engl J Med 2006, 354:2443-2451.
64. Hod M., van Dijk D.J., Karp M., et al. Diabetic nephropathy and pregnancy: the effect of ACE inhibitors prior to pregnancy on fetomaternal outcome. Nephrol Dial Transplant 1995, 10:2328-2333.
65. Friedman S., Rabinerson D., Bar J., et al. Microalbuminuria following gestational diabetes. Acta Obstet Gynecol Scand 1995, 74:356-360.
66. Go R.C., Desmond R., Roseman J.M., et al. Prevalence and risk factors of microalbuminuria in a cohort of African-American women with gestational diabetes. Diabetes Care 2001, 24:1764-1769.
67. Carr D.B., Utzschneider K.M., Hull R.L., et al. Gestational diabetes mellitus increases the risk of cardiovascular disease in women with a family history of type 2 diabetes. Diabetes Care 2006, 29:2078-2083.
68. Kim C., Cheng Y.J., Beckles G.L. Cardiovascular disease risk profiles in women with histories of gestational diabetes but without current diabetes. Obstet Gynecol 2008, 112:875-883.
69. Kim C., Newton K.M., Knopp R.H. Gestational diabetes and the incidence of type 2 diabetes: a systematic review. Diabetes Care 2002, 25:1862-1868.
70. Effect of pregnancy on microvascular complications in the diabetes control and complications trial. Diabetes Care 2000, 23:1084-1091. The Diabetes Control and Complications Trial Research Group.
71. Hemachandra A., Ellis D., Lloyd C.E., Orchard T.J. The influence of pregnancy on IDDM complications. Diabetes Care 1995, 18:950-954.
72. Rossing K., Jacobsen P., Hommel E., et al. Pregnancy and progression of diabetic nephropathy. Diabetologia 2002, 45:36-41.
73. Miodovnik M., Rosenn B.M., Khoury J.C., Grigsby J.L., Siddiqi T.A. Does pregnancy increase the risk for development and progression of diabetic nephropathy? Am J Obstet Gynecol 1996, 174:1180-1191.
74. Vikse B.E., Irgens L.M., Leivestad T., Skjaerven R., Iversen B.M. Preeclampsia and the risk of end-stage renal disease. N Engl J Med 2008, 359:800-809.
75. Gordin D., Hiilesmaa V., Fagerudd J., et al. Pre-eclampsia but not pregnancy-induced hypertension is a risk factor for diabetic nephropathy in type 1 diabetic women. Diabetologia 2007, 50:516-522.